Riskpilot← Back to searchSign inGet full accessUdviklingshuset Brain & Body ApS
APSActiveCVR 39588927Aurehøjvej 2, st. thOther education n.e.c. · NACE 8559Est. 20183 employeeswww.brainandbody.dk
Revenue 2025
DKK 2,1M
0% vs 2024
EBITDA margin
19.7%
-44% vs 2024
Equity ratio
61.4%
Financial strength
Net profit 2025
DKK 289K
-49% vs 2024
| Revenue | DKK 2,1M | +0% |
| EBITDA | DKK 404K | -44% |
| Net profit | DKK 289K | -49% |
| Total assets | DKK 1,7M | +22% |
| Equity | DKK 1M | +39% |
| Employees | 3 | — |
Legal name
Udviklingshuset Brain & Body ApS
CVR number
39588927
Legal form
Anpartsselskab
NACE code
8559 · Other education n.e.c.
Founded
22. maj 2018
Share capital
DKK 50.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør
Company purpose
Selskabets formål er at drive konsulent- og projektvirksomhed og at være leverandør til jobcentre inden for beskæftigelse og integration samt hermed beslægtede aktiviteter.
Address
Aurehøjvej 2, st. th
Phone
+4526198228
Email
info@brainandbody.dk
Website
www.brainandbody.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 514 | 1.267 | 1.862 | 1.852 | 2.021 | 2.054 | 2.052 |
| Staff expenses | -514 | -1.362 | -1.898 | -1.934 | -1.596 | -1.332 | -1.647 |
| EBITDA | 1 | -95 | -36 | -82 | 425 | 721 | 404 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -17 |
| EBIT | 1 | -95 | -36 | -82 | 425 | 721 | 387 |
| Net financials | -4 | -7 | -4 | -13 | -7 | -0 | -8 |
| Profit before tax | -3 | -102 | -41 | -95 | 418 | 721 | 378 |
| Tax | 2 | -20 | -9 | -19 | 94 | 159 | 89 |
| Net profit | -5 | -82 | -32 | -76 | 324 | 562 | 289 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 494 | 280 | 583 | 410 | 658 | 1.374 | 1.679 |
| Equity | 45 | -37 | -69 | -145 | 179 | 741 | 1.030 |
| Long-term debt | 2 | 36 | 96 | 44 | 8 | 230 | 0 |
| Short-term debt | 447 | 281 | 555 | 511 | 471 | 403 | 645 |
| Total debt | 449 | 317 | 652 | 555 | 479 | 632 | 645 |
EBITDA margin
19.7%
This company
15.8%
Market median
+25% vs market
20192025
Equity ratio
61.4%
This company
38.2%
Market median
+61% vs market
20192025
Return on equity
28.1%
This company
18.4%
Market median
+53% vs market
20192025
Net profit margin
14.1%
This company
8.1%
Market median
+74% vs market
20192025
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20192025
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20192025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-22 – 2019-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AB Management | Management | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bliv Glad Igen Holding ApS | Company | 100.0% | 100.0% | 2024 |
| Individual | 50.0% | 50.0% | 2018 | |
| Individual | 50.0% | 50.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bliv Glad Igen Holding ApS
Udviklingshuset Brain & Body ApS Board members of Udviklingshuset Brain & Body ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Bettina Pilegaard Belmadani | Management | 0 companies |